Literature DB >> 28050630

Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a 13NH3 gated PET study.

Roberto Sciagrà1, Raffaella Calabretta2, Fabrizio Cipollini3, Alessandro Passeri2, Angelo Castello2, Franco Cecchi4, Iacopo Olivotto4, Alberto Pupi2.   

Abstract

INTRODUCTION: Ischemia in hypertrophic cardiomyopathy (HCM) is caused by coronary microvascular dysfunction (CMD), which is detected by measuring myocardial blood flow (MBF) with PET. Whether CMD may be associated with ischemic left ventricular (LV) dysfunction is unclear. We therefore assessed LV ejection fraction (EF) reserve in HCM patients undergoing dipyridamole (Dip) PET.
METHODS: Resting and stress 13NH3 dynamic as well as gated PET were performed in 34 HCM patients. Segmental MBF and transmural perfusion gradient (TPG = subendocardial / subepicardial MBF) were assessed. LVEF reserve was considered abnormal if Dip LVEF decreased more than 5 units as compared to rest.
RESULTS: Eighteen patients had preserved (group A) and 16 abnormal LVEF reserve (group B; range -7 to -32). Group B patients had greater wall thickness than group A, but resting volumes, LVEF, resting and Dip MBF, and myocardial flow reserve were similar. Group B had slightly higher summed stress score and summed difference score in visual analysis than group A, and a significantly higher summed stress wall motion score. In group B, resting TPG was slightly lower (1.31 ± 0.29 vs. 1.37 ± 0.34, p <0.05), and further decreased after Dip, whilst in group A it increased (B = 1.20 ± 0.39, p < 0.0001 vs. rest and vs. A = 1.40 ± 0.43). The number of segments per patient with TPG <1 was higher than in group A (p < 0.001) and was a significant predictor of impaired LVEF reserve (OR 1.86, p < 0.02), together with wall thickness (OR 1.3, p < 0.02).
CONCLUSION: Abnormal LVEF response is common in HCM patients following Dip, and is related to abnormal TPG, suggesting that subendocardial ischemia might occur under Dip and cause transient LV dysfunction. Although in vivo this effect may be hindered by the adrenergic drive associated with effort, these findings may have relevance in understanding exercise limitation and heart failure symptoms in HCM.

Entities:  

Keywords:  Hypertrophic Cardiomyopathy; Left Ventricular Ejection Fraction; Myocardial Blood Flow; N-13-Ammonia; Positron Emission Tomography

Mesh:

Substances:

Year:  2017        PMID: 28050630     DOI: 10.1007/s00259-016-3603-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  47 in total

Review 1.  Quantification of myocardial blood flow and flow reserve: Technical aspects.

Authors:  Ran Klein; Rob S B Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

2.  Parametric images of myocardial viability using a single 15O-H2O PET/CT scan.

Authors:  Hendrik J Harms; Stefan de Haan; Paul Knaapen; Cornelis P Allaart; Adriaan A Lammertsma; Mark Lubberink
Journal:  J Nucl Med       Date:  2011-04-15       Impact factor: 10.057

3.  Enhanced definition PET for cardiac imaging.

Authors:  Ludovic Le Meunier; Piotr J Slomka; Damini Dey; Amit Ramesh; Louis E J Thomson; Sean W Hayes; John D Friedman; Victor Cheng; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2010-02-12       Impact factor: 5.952

4.  Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy.

Authors:  K Okeie; M Shimizu; H Yoshio; H Ino; M Yamaguchi; T Matsuyama; T Yasuda; J Taki; H Mabuchi
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

5.  Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography.

Authors:  T R DeGrado; M W Hanson; T G Turkington; D M Delong; D A Brezinski; J P Vallée; L W Hedlund; J Zhang; F Cobb; M J Sullivan; R E Coleman
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

6.  The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated (82)Rb PET myocardial perfusion imaging.

Authors:  Andrew Van Tosh; John R Votaw; Nathaniel Reichek; Christopher J Palestro; Kenneth J Nichols
Journal:  J Nucl Cardiol       Date:  2013-10-04       Impact factor: 5.952

Review 7.  Clinical myocardial perfusion PET/CT.

Authors:  Marcelo F Di Carli; Sharmila Dorbala; Jolene Meserve; Georges El Fakhri; Arkadiusz Sitek; Stephen C Moore
Journal:  J Nucl Med       Date:  2007-05       Impact factor: 10.057

8.  Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.

Authors:  Sharmila Dorbala; Rory Hachamovitch; Zelmira Curillova; Deepak Thomas; Divya Vangala; Raymond Y Kwong; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

9.  Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy.

Authors:  N Yoshida; H Ikeda; T Wada; A Matsumoto; S Maki; A Muro; A Shibata; T Imaizumi
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

10.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Franco Cecchi; Roberto Gistri; Roberto Lorenzoni; Giampaolo Chiriatti; Francesca Girolami; Francesca Torricelli; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2006-03-07       Impact factor: 24.094

View more
  9 in total

Review 1.  Quantification of PET Myocardial Blood Flow.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Georges El Fakhri
Journal:  Curr Cardiol Rep       Date:  2019-02-28       Impact factor: 2.931

2.  Radionuclide imaging of subendocardial ischaemia: an insight into coronary pathophysiology or a technical artefact?

Authors:  Gianmario Sambuceti; Silvia Morbelli; Alessandro Bellini; Cecilia Marini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02-08       Impact factor: 9.236

Review 3.  Microvascular Angina Diagnosed by Absolute PET Myocardial Blood Flow Quantification.

Authors:  Matthieu Pelletier-Galarneau; Vasken Dilsizian
Journal:  Curr Cardiol Rep       Date:  2020-01-28       Impact factor: 2.931

4.  Coronary microvascular disease in hypertrophic and infiltrative cardiomyopathies.

Authors:  Andreas A Giannopoulos; Ronny R Buechel; Philipp A Kaufmann
Journal:  J Nucl Cardiol       Date:  2022-08-01       Impact factor: 3.872

5.  Right atrial function assessed by volume-derived values and speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  Jun Huang; Chao Yang; Cai-Fang Ni; Zi-Ning Yan; Li Fan; Xiang-Ting Song
Journal:  BMC Cardiovasc Disord       Date:  2020-07-13       Impact factor: 2.298

6.  Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy.

Authors:  Min Zhao; Min Liu; Jeffrey P Leal; Benjamin M W Tsui; Dean F Wong; Martin G Pomper; Yun Zhou
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

7.  EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging.

Authors:  Roberto Sciagrà; Mark Lubberink; Fabien Hyafil; Antti Saraste; Riemer H J A Slart; Denis Agostini; Carmela Nappi; Panagiotis Georgoulias; Jan Bucerius; Christoph Rischpler; Hein J Verberne
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-02       Impact factor: 9.236

8.  Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.

Authors:  Xin Huang; Yan Yue; Yinmeng Wang; Yujiao Deng; Lu Liu; Yanqi Di; Shasha Sun; Deyou Chen; Li Fan; Jian Cao
Journal:  Cardiovasc Ultrasound       Date:  2018-10-02       Impact factor: 2.062

9.  Positron emission tomography (15O-water, 11C-acetate, 11C-HED) risk markers and nonsustained ventricular tachycardia in hypertrophic cardiomyopathy.

Authors:  Peter Magnusson; Jonny Nordström; Hendrik J Harms; Mark Lubberink; Fredrik Gadler; Jens Sörensen; Stellan Mörner
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.